Glaucoma causes progressive damage and death of retinal ganglion cells (RGCs) resulting in blindness. The prevalence of the disease will rise to a projected 3 million Americans by 2020. Our long-term goal is to prevent RGC death in the early stages of glaucoma and preserve vision. The objective of this study is to identify dysfunctional RGCs and the risk of their death, together with the time window of opportunity for their recovery. Our central hypothesis is that RGCs undergo a stage of reversible dysfunction before dying, and that RGC dysfunction is modifiable in a critical period during which RGC electrical activity is responsive to artificial elevation/lowering of the intraocular pressure (IOP). Temporary IOP elevation with be obtained by means of head-down body posture;IOP lowering will be obtained by means of topical treatment. Our study will include 600 subjects with suspicion of glaucoma but with normal vision and visual field that will be longitudinally monitored over 4 years with state-of-the-art pattern electroretinogram (PERG), Spectral-domain Optical Coherence Tomography (SD-OCT), and other clinical measures. PERG losses result from reduced activity of viable RGCs as well as from lack of activity from dead/missing RGCs;OCT losses result from loss of RGC/axon tissue.
Our specific aims will determine the risk of losing substantial RGC/axon tissue over 4 years based on baseline PERG susceptibility to head-down posture (aim1), baseline PERG abnormality (aim 2), and presence/absence of IOP-lowering treatment during follow up. Successful completion of our research will establish the notion that RGC death in glaucoma is preceded by a defined stage of modifiable RGC electrical activity, and that the risk of developing glaucoma can be predicted at baseline based on PERG. The outcome of our research will provide 1) the basis for new provocative tests of RGC functional susceptibility/reversibility using a non-invasive PERG method, 2) information needed for new methods to predict the risk of glaucoma development , 3) the time window for preventing it by timely treatment of high-risk individuals.

Public Health Relevance

In subjects suspected of having glaucoma, the electrical activity of retinal ganglion cells - non- invasively measured by pattern electroretinogram - may be altered or may become temporarily altered when subjects assume a head-down body posture. Altered electrical activity may predict future loss of optic nerve tissue and determine th necessity of intraocular pressure-lowering treatment. Treatment may improve electrical activity and prevent tissue loss. Thus, pattern electroretinogram biomarkers have great relevance for clinical management of the disease.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY014957-09A1
Application #
8691270
Study Section
(DPVS)
Program Officer
Chin, Hemin R
Project Start
2003-07-01
Project End
2018-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
9
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Panarelli, Joseph F; Banitt, Michael R; Sidoti, Paul A et al. (2015) Clinical impact of 8 prospective, randomized, multicenter glaucoma trials. J Glaucoma 24:64-8
Porciatti, Vittorio (2015) Electrophysiological assessment of retinal ganglion cell function. Exp Eye Res 141:164-70
Panarelli, Joseph F; Banitt, Michael R; Sidoti, Paul A (2014) Transscleral diode laser cyclophotocoagulation after baerveldt glaucoma implant surgery. J Glaucoma 23:405-9
Porciatti, Vittorio; Bosse, Brandon; Parekh, Prashant K et al. (2014) Adaptation of the steady-state PERG in early glaucoma. J Glaucoma 23:494-500
Özdamar, Özcan; Toft-Nielsen, Jonathon; Bohórquez, Jorge et al. (2014) Relationship between transient and steady-state pattern electroretinograms: theoretical and experimental assessment. Invest Ophthalmol Vis Sci 55:8560-70
Guy, John; Feuer, William J; Porciatti, Vittorio et al. (2014) Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 55:841-8
Lam, Byron L; Feuer, William J; Schiffman, Joyce C et al. (2014) Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial. JAMA Ophthalmol 132:428-36
Ventura, Lori M; Golubev, Iuri; Lee, William et al. (2013) Head-down posture induces PERG alterations in early glaucoma. J Glaucoma 22:255-64
Banitt, Michael (2013) The choroid in glaucoma. Curr Opin Ophthalmol 24:125-9
Ventura, Lori M; Golubev, Iuri; Feuer, William J et al. (2013) Pattern electroretinogram progression in glaucoma suspects. J Glaucoma 22:219-25

Showing the most recent 10 out of 35 publications